What is he best known for?
The fields of study he is best known for:
Amalio Telenti mainly focuses on Immunology, Genetics, Virology, Acquired immunodeficiency syndrome and Internal medicine.
Amalio Telenti works in the field of Immunology, namely Viral load.
In his study, which falls under the umbrella issue of Genetics, Antibacterial agent, Polymerase chain reaction and Gene is strongly linked to Mycobacterium tuberculosis.
His Virology study combines topics in areas such as T cell, NK-92, Interleukin 12, Antibody and Chemokine receptor.
His work on Sida as part of his general Acquired immunodeficiency syndrome study is frequently connected to International community, thereby bridging the divide between different branches of science.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Surgery, Gastroenterology, Efavirenz and Ritonavir.
His most cited work include:
- Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)
- Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. (1254 citations)
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (1068 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Genetics, Virology, Immunology, Gene and Genome.
His studies in Virology integrate themes in fields like Antibody, Monoclonal antibody and Antigen.
His Immunology study combines topics from a wide range of disciplines, such as Internal medicine and Acquired immunodeficiency syndrome.
While the research belongs to areas of Internal medicine, Amalio Telenti spends his time largely on the problem of Efavirenz, intersecting his research to questions surrounding Reverse-transcriptase inhibitor, Lopinavir, Ritonavir, Nelfinavir and Indinavir.
As part of his studies on Gene, Amalio Telenti often connects relevant subjects like Microbiology.
His Genome research integrates issues from Exome sequencing and Computational biology.
He most often published in these fields:
- Genetics (29.18%)
- Virology (25.17%)
- Immunology (23.61%)
What were the highlights of his more recent work (between 2015-2021)?
- Genetics (29.18%)
- Genome (14.70%)
- Computational biology (10.24%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Genetics, Genome, Computational biology, Gene and Genomics.
His study on Whole genome sequencing, Genome-wide association study, Retinitis pigmentosa and Allele frequency is often connected to Identification as part of broader study in Genetics.
His Gene course of study focuses on Microbiology and Flora, Urine, 16S ribosomal RNA and Metagenomics.
His study explores the link between Transcriptome and topics such as Single cell sequencing that cross with problems in Virology.
His work deals with themes such as Immunology and Intensive care medicine, which intersect with Disease.
Amalio Telenti is involved in the study of Immunology that focuses on Immune system in particular.
Between 2015 and 2021, his most popular works were:
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. (585 citations)
- Deep sequencing of 10,000 human genomes. (218 citations)
- A primer on deep learning in genomics. (214 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Virology, Gene, Genetics, Human genome and Genome.
Amalio Telenti combines subjects such as Antibody and GTPase with his study of Virology.
His research in Gene intersects with topics in Infectivity, Interferon, Guanosine and Effector.
His Genetics research is multidisciplinary, relying on both Disease and Metabolomics.
The concepts of his Genome study are interwoven with issues in Contrast, Computational biology and Allele frequency.
His Carcinogenesis study integrates concerns from other disciplines, such as Immunology and Metagenomics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
